The Chk2 Tumor Suppressor Is Not Required for p53 Responses in Human Cancer Cells
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Ionizing radiation damages chromosomal DNA and activates p53-dependent transcription in mammalian cells. The Chk2 protein kinase has been hypothesized to be the primary mediator of this response. We have rigorously tested this hypothesis in human cells by disrupting the CHK2 gene through homologous recombination. We found that the p53 response was unexpectedly robust in such cells. Phosphorylation of p53 at serine 20, accumulation of p53 protein, transcriptional activation of p53 target genes, and cell cycle arrest and apoptotic death phenotypes were completely intact regardless of CHK2 status. Our results indicate that Chk2 kinase is not required for p53 activation in human cells and explain why CHK2 and TP53 mutations can jointly occur in human tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The results in Figure 9C were unexpected since a previous study using the same HCT116-Chk2À/À cell line reported that Chk2 knockout did not affect p53 response to higher doses (12 Gy) of ionizing irradiation (Jallepalli et al, 2003).”
From ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage (2005) · cites this paper as Jallepalli et al, 2003
The cited source says what the claim attributes to it.
In the citing paper
“Although a role of ATM in p53 response is well established, the significance of Chk2 is still a matter of debate.”
From ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage (2005) · cites this paper as Jallepalli et al, 2003
In the citing paper
“A major caveat of this interpretation is that Chk2 does not seem to play an essential role in G2 arrest 84,85,72 and it is more likely that damaged cells progress into mitosis due to inefficient Chk1 activation 86 and/or lack of robust p21 induction.”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [85]
In the citing paper
“Studies using Chk2-null mice, Chk2-null HCT116 cells, and Chk2 siRNA resulted in different conclusions (Zhang et al, 1998;Chehab et al, 2000;Shieh et al, 2000;Ahn et al, 2003; Jallepalli et al, 2003).”
From ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage (2005) · cites this paper as Jallepalli et al, 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Self-citationRequirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Self-citationCell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,451
Self-citationLinkage of ATM to Cell Cycle Regulation by the Chk2 Protein Kinase
Matsuoka, S. (1998) · Science · doi:10.1126/science.282.5395.1893 · Cited by 1,322
Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H., & Elledge, S. J. (1997) · Science · doi:10.1126/science.277.5331.1497 · Cited by 1,320
The complexity of p53 modulation: emerging patterns from divergent signals
Giaccia, A. J., & Kastan, M. B. (1998) · Genes & Development · doi:10.1101/gad.12.19.2973 · Cited by 1,314
DNA Damage-Induced Activation of p53 by the Checkpoint Kinase Chk2
Hirao, A., Kong, Y.-Y., Matsuoka, S., Wakeham, A., Ruland, J., Yoshida, H., Liu, D., Elledge, S. J., & Mak, T. W. (2000) · Science · doi:10.1126/science.287.5459.1824 · Cited by 1,285
RAF/RAS oncogenes and mismatch-repair status
Rajagopalan, H., Bardelli, A., Lengauer, C., Kinzler, K. W., Vogelstein, B., & Velculescu, V. E. (2002) · Nature · doi:10.1038/418934a · Cited by 1,224
Self-citation
Research works printed but not linked: 8
- Dumaz, N., Milne, D. M., Jardine, L. J., and Meek, D. W. (2001) Biochem. J. 359, 459 -464 · doi:10.1042/bj3590459 · Paper page
- Lee, S. B., Kim, S. H., Bell, D. W., Wahrer, D. C., Schiripo, T. A., Jorczak, M. M., Sgroi, D. C., Garber, J. E., Li, F. P., Nichols, K. E., Varley, J. M., Godwin, A. K., Shannon, K. M., Harlow, E., and Haber, D. A. (2001) Cancer Res. 61, 8062-8067
- Canman, C. E., Wolff, A. C., Chen, C. Y., Fornace, A. J., Jr., and Kastan, M. B. (1994) Cancer Res. 54, 5054 -5058
- Ahn, J. Y., Schwarz, J. K., Piwnica-Worms, H., and Canman, C. E. (2000) Cancer Res. 60, 5934 -5936
- Sparks, A. B., Morin, P. J., Vogelstein, B., and Kinzler, K. W. (1998) Cancer Res. 58, 1130 -1134
- Yu, Q., La Rose, J., Zhang, H., Takemura, H., Kohn, K. W., and Pommier, Y. (2002) Cancer Res. 62, 5743-5748
- Waldman, T., Kinzler, K. W., and Vogelstein, B. (1995) Cancer Res. 55, 5187-5190
- Brown, K. D., Rathi, A., Kamath, R., Beardsley, D. I., Zhan, Q., Mannino, J. L., and Baskaran, R. (2002) Nat. Genet. 25, 25
Cited by
Chk1 and Chk2 kinases in checkpoint control and cancer
Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00110-7 · Cited by 1,513
The ATM–Chk2 and ATR–Chk1 Pathways in DNA Damage Signaling and Cancer
(2010) · Advances in Cancer Research · doi:10.1016/b978-0-12-380888-2.00003-0 · Cited by 1,276
Phosphorylation of HuR by Chk2 Regulates SIRT1 Expression
Abdelmohsen, K., Pullmann, R., Lal, A., Kim, H. H., Galban, S., Yang, X., Blethrow, J. D., Walker, M., Shubert, J., Gillespie, D. A., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.01.011 · Cited by 527
Rodier, F., Muñoz, D. P., Teachenor, R., Chu, V., Le, O., Bhaumik, D., Coppé, J.-P., Campeau, E., Beauséjour, C. M., Kim, S.-H., et al. (2011) · Journal of Cell Science · doi:10.1242/jcs.071340 · Cited by 535
DNA damage-induced activation of ATM and ATM-dependent signaling pathways
Kurz, E. U., & Lees-Miller, S. P. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.03.029 · Cited by 478
CHK2 kinase in the DNA damage response and beyond
Zannini, L., Delia, D., & Buscemi, G. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mju045 · Cited by 455
“Subsequent studies disputed this finding (Ahn et al., 2003; Jallepalli et al., 2003).”
Principles for the post-GWAS functional characterization of cancer risk loci
Freedman, M. L., Monteiro, A. N. A., Gayther, S. A., Coetzee, G. A., Risch, A., Plass, C., Casey, G., De Biasi, M., Carlson, C., Duggan, D., et al. (2011) · Nature Genetics · doi:10.1038/ng.840 · Cited by 438
Targeting the checkpoint kinases: chemosensitization versus chemoprotection
Zhou, B.-B. S., & Bartek, J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1296 · Cited by 391
“The observation that knockdown or knockout of CHK2 in the human HCT116 colon cancer cell line does not affect Ser20 phosphorylatio”
BackgroundKajita, M., McClinic, K. N., & Wade, P. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7559-7566.2004 · Cited by 333
“The checkpoint kinase CHK2 has been implicated in p53 stabilization through phosphorylation of the protein after DNA damage in mouse cells (17), although the relevance of this observation in human cells has recently been questioned (1, 22).”
BackgroundA Role for the Deubiquitinating Enzyme USP28 in Control of the DNA-Damage Response
Zhang, D., Zaugg, K., Mak, T. W., & Elledge, S. J. (2006) · Cell · doi:10.1016/j.cell.2006.06.039 · Cited by 326
ATR-Chk2 Signaling in p53 Activation and DNA Damage Response during Cisplatin-induced Apoptosis
Pabla, N., Huang, S., Mi, Q.-S., Daniel, R., & Dong, Z. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707568200 · Cited by 309
microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells
Wang, P., Zou, F., Zhang, X., Li, H., Dulak, A., Tomko, R. J., Lazo, J. S., Wang, Z., Zhang, L., & Yu, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1996 · Cited by 308
Senescence from G2 arrest, revisited
Gire, V., & Dulić, V. (2015) · Cell Cycle · doi:10.1080/15384101.2014.1000134 · Cited by 300
CHK2 kinase: cancer susceptibility and cancer therapy – two sides of the same coin?
Antoni, L., Sodha, N., Collins, I., & Garrett, M. D. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2251 · Cited by 288
Control of the G2/M Transition
Stark, G. R., & Taylor, W. R. (2006) · Molecular Biotechnology · doi:10.1385/mb:32:3:227 · Cited by 279
Ataxia-telangiectasia-like disorder (ATLD)—its clinical presentation and molecular basis
Taylor, A. M. R., Groom, A., & Byrd, P. J. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.04.009 · Cited by 269
ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage
Chen, L., Gilkes, D. M., Pan, Y., Lane, W. S., & Chen, J. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600812 · Cited by 260
“The lysate was precleared with 100 ml bed volume of protein A sepharose beads for 30 min, and then incubated with 50 ml bed volume of M2-agarose bead (Sigma) for 4 h at 41C.”
BackgroundMethodResultInfluentialAhn, J., Urist, M., & Prives, C. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.03.033 · Cited by 240
p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2
Urist, M., Tanaka, T., Poyurovsky, M. V., & Prives, C. (2004) · Genes & Development · doi:10.1101/gad.1221004 · Cited by 234
“2003) or deletion of both Chk2 alleles in HCT116 cells (Jallepalli et al. 2003) does not impact p53 stabilization or activation.”
BackgroundIncreased microtubule assembly rates influence chromosomal instability in colorectal cancer cells
Ertych, N., Stolz, A., Stenzinger, A., Weichert, W., Kaulfuß, S., Burfeind, P., Aigner, A., Wordeman, L., & Bastians, H. (2014) · Nature Cell Biology · doi:10.1038/ncb2994 · Cited by 213
Silverman, J., Takai, H., Buonomo, S. B. C., Eisenhaber, F., & de Lange, T. (2004) · Genes & Development · doi:10.1101/gad.1216004 · Cited by 207
“…or pLPC were grown in DMEM/10% BCS. U-2OS cells (ATCC) and HCT116 Chk2−/−; cells (a gift from P. Jallipalli, Memorial Sloan-Kettering Cancer Center, New York, NY; Jallepalli et al. 2003) were grown in McCoy’s 5A/10% FBS. HCC1937 cells (ATCC) were grown in RPMI/10% FBS and 1 mM sodium pyruvate.”
BackgroundMethodDNA damage tolerance: a double-edged sword guarding the genome.
Ghosal, G., & Chen, J. (2013) · PubMed · doi:10.3978/j.issn.2218-676x.2013.04.01 · Cited by 190
“Similarly, depletion or inactivation of ATR or Chk1, but not ATM or Chk2, affects cell viability (47,71-73).”
BackgroundOu, Y.-H., Chung, P.-H., Sun, T.-P., & Shieh, S.-Y. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-08-0689 · Cited by 198
“Al- though it is possible that CHK1 or CHK2 is involved in these phosphorylation events in vivo, gene knockout or ablation by siRNA in certain cancer cell lines seriously questions this possibility (Jallepalli et al., 2003; Ahn et al., 2003).”
BackgroundMethodInfluentialChk1 in the DNA damage response: conserved roles from yeasts to mammals
Chen, Y., & Sanchez, Y. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.03.003 · Cited by 196
CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate
Stolarova, L., Kleiblova, P., Janatova, M., Soukupova, J., Zemankova, P., Macurek, L., & Kleibl, Z. (2020) · Cells · doi:10.3390/cells9122675 · Cited by 190
“In agreement with this, no checkpoint defect was observed in HCT116 cells lacking CHK2 and thus the impact of CHK2 on the p53 pathway remains unclear [33,81].”
BackgroundMedema, R. H., & Macůrek, L. (2012) · Oncogene · doi:10.1038/onc.2011.451 · Cited by 177
Crosstalk of the mitotic spindle assembly checkpoint with p53 to prevent polyploidy
Vogel, C., Kienitz, A., Hofmann, I., Müller, R., & Bastians, H. (2004) · Oncogene · doi:10.1038/sj.onc.1207860 · Cited by 168
“To test whether Chk2 is involved in p53 activation in response to spindle damage, we used recently established HCT116 cells homozygously deleted for CHK2 (Jallepalli et al., 2003).”
MethodInfluentialUbiquitin‐mediated proteolysis of HuR by heat shock
Abdelmohsen, K., Srikantan, S., Yang, X., Lal, A., Kim, H. H., Kuwano, Y., Galban, S., Becker, K. G., Kamara, D., de Cabo, R., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.67 · Cited by 158
“Supporting the notion that CHK2 might ameliorate HuR degradation, HeLa cells treated with a CHK2 inhibitor showed a similarly accelerated loss of HuR after HS (Figure 4B).”
BackgroundMethodInfluentialThe CHK2–BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells
Stolz, A., Ertych, N., Kienitz, A., Vogel, C., Schneider, V., Fritz, B., Jacob, R., Dittmar, G., Weichert, W., Petersen, I., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2051 · Cited by 161
“Karyotype analysis of chromosomal-stable HCT116 and isogenic CHK2 and TP53 knockout cells (HCT- CHK2 −/− , ref”
BackgroundE2F1 Uses the ATM Signaling Pathway to Induce p53 and Chk2 Phosphorylation and Apoptosis
Powers, J. T., Hong, S., Mayhew, C. N., Rogers, P. M., Knudsen, E. S., & Johnson, D. G. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.203.2.4 · Cited by 152
Zheng, M., Ekmekçioglu, S., Walch, E. T., Tang, C., & Grimm, E. A. (2004) · Melanoma Research · doi:10.1097/01.cmr.0000129374.76399.19 · Cited by 144
Depletion of Chk1 Leads to Premature Activation of Cdc2-cyclin B and Mitotic Catastrophe
Niida, H., Tsuge, S., Katsuno, Y., Konishi, A., Takeda, N., & Nakanishi, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505009200 · Cited by 137
The p53 protein family and radiation sensitivity: Yes or no?
Cuddihy, A. R., & Bristow, R. G. (2004) · Cancer and Metastasis Reviews · doi:10.1023/b:canc.0000031764.81141.e4 · Cited by 153
Gemcitabine-Induced Activation of Checkpoint Signaling Pathways That Affect Tumor Cell Survival
Karnitz, L. M., Flatten, K. S., Wagner, J. M., Loegering, D. A., Hackbarth, J. S., Arlander, S. J. H., Vroman, B. T., Thomas, M. B., Baek, Y.-U., Hopkins, K. M., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012716 · Cited by 148
“A similar conclusion has been reached regarding the role of Chk2 in the response to other genotoxic stresses (Jallepalli et al., 2003).”
BackgroundMethodInfluentialMaclaine, N. J., & Hupp, T. R. (2009) · Aging · doi:10.18632/aging.100047 · Cited by 130
“The use of siRNA to CHK1 or CHK2 does not abrogate the damage-induced stabilization of p53 [43], and the knockout of CHK2 in cancer cell lines does not compromise Ser20 site phosphorylation [44].”
BackgroundDefective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23
MacPherson, D., Kim, J., Kim, T., Rhee, B. K., van Oostrom, C. T., DiTullio, R. A., Venere, M., Halazonetis, T. D., Bronson, R., de Vries, A., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600363 · Cited by 124
“Finally, recent data demonstrate that Chk2 function is not essential for Ser20 phosphorylation, as p53 can be efficiently phosphorylated on Ser20 in Chk2 / cells (Takai et al, 2002; Jallepalli et al, 2003).”
BackgroundRegulation of MDMX nuclear import and degradation by Chk2 and 14-3-3
LeBron, C., Chen, L., Gilkes, D. M., & Chen, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601032 · Cited by 122
“As expected, DNA damage by g irradiation or UV induced S367 phosphorylation in wild-type HCT116 cells, but not in HCT116-Chk2 / cells (Figure 4A) (Jallepalli et al, 2003).”
BackgroundTumor Suppressor CHK2: Regulator of DNA Damage Response and Mediator of Chromosomal Stability
Stolz, A., Ertych, N., & Bastians, H. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1215 · Cited by 136
“human cell lines challenged these results and showed no requirement of Chk2 for the stabilization of p53 after DNA damage (8, 12, 13).”
BackgroundLi, L., & Zou, L. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20355 · Cited by 115
“However, the role of Chk2 in p53 regulationwas recently questioned by two studies using a humanChk2 knockout cell line and small interfering RNA against human Chk2 [Ahn et al., 2003; Jallepalli et al., 2003].”
BackgroundRegulation of p53 Stability and Function in HCT116 Colon Cancer Cells
Kaeser, M. D., Pebernard, S., & Iggo, R. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311732200 · Cited by 112
Solier, S., Sordet, O., Kohn, K. W., & Pommier, Y. G. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00581-08 · Cited by 126
“To further examine the functional role of Chk2 in apoptosis, we also performed experiments with Chk2 knockout cells (24).”
MethodActivation of ATM and Chk2 kinases in relation to the amount of DNA strand breaks
Buscemi, G., Perego, P., Carenini, N., Nakanishi, M., Chessa, L., Chen, J., Khanna, K. K., & Delia, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207986 · Cited by 146
“…D Delia; E-mail: domenico.delia@istitutotumori.mi.it Oncogene (2004) 23, 7691–7700 & 2004 Nature Publishing Group All rights reserved 0950-9232/04 $30.00 www.nature.com/onc phosphorylation of p53-Ser20 by Chk2 has been recently questioned (Ahn et al., 2003; Jallepalli et al., 2003).”
BackgroundMethodInfluentialThe Role of Checkpoint Kinase 1 in Sensitivity to Topoisomerase I Poisons
Flatten, K., Dai, N. T., Vroman, B. T., Loegering, D., Erlichman, C., Karnitz, L. M., & Kaufmann, S. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411890200 · Cited by 103
Chu, K., Teele, N., Dewey, M. W., Albright, N., & Dewey, W. C. (2004) · Radiation Research · doi:10.1667/rr3221 · Cited by 120
Questioning the Role of Checkpoint Kinase 2 in the p53 DNA Damage Response
Ahn, J., Urist, M., & Prives, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213185200 · Cited by 99
Chrisanthar, R., Knappskog, S., Løkkevik, E., Anker, G. B., Østenstad, B., Lundgren, S., Berge, E. O., Risberg, T., Mjaaland, I., Mæhle, L., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003062 · Cited by 103
“While experimental studies have suggested a critical role of Chk2 in activating p53 apoptotic response to genotoxic stress [21,22], others claim Chk2 to be dispensable for p53 activation with respect to apoptosis as well as growth arrest [23].”
BackgroundTse, A. N., & Schwartz, G. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0841 · Cited by 92
“However, two recent reports have shown that the p53 response to DNA damage was apparently intact in cell lines where chk2 was depleted by either gene knockout technique (16) or small interfering RNA (17), therefore, questioning the role of chk2 in activating p53.”
BackgroundGenetic instability in cancer cells by impaired cell cycle checkpoints
Nakanishi, M., Shimada, M., & Niida, H. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00289.x · Cited by 105
Kleiblová, P., Stolařová, L., Křížová, K., Lhota, F., Hojny, J., Zemánková, P., Havránek, O., Vočka, M., Černá, M., Lhotová, K., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32385 · Cited by 92
RAD51C facilitates checkpoint signaling by promoting CHK2 phosphorylation
Badie, S., Liao, C., Thanasoula, M., Barber, P., Hill, M. A., & Tarsounas, M. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200811079 · Cited by 89
“HeLa 1.2.11 (Tarsounas et al., 2004b), U2OS, HCT116 wild-type, and Chk2/ cells (a gift from F. Bunz, John Hopkins University, Baltimore, MD; Jallepalli et al., 2003), and NBS1 LB1 cells infected with pLPC-NBS1 or pLPC (a gift from M. Zdziencka, University of Leiden, Leiden, Netherlands;…”
InfluentialDross, R. V., Xue, Y. Z., Knudson, A., & Pelling, J. C. (2003) · Journal of Nutrition · doi:10.1093/jn/133.11.3800s · Cited by 90
Comparison of hypoxia-induced replication arrest with hydroxyurea and aphidicolin-induced arrest
Hammond, E. M., Green, S., & Giaccia, A. J. (2003) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2003.08.017 · Cited by 105
“This was recently called into question however, by the finding that serine 20 was still phosphorylated in Chk 2 null cells in response to DNA damage [ 29 ].”
BackgroundCarlessi, L., Buscemi, G., Larson, G., Hong, Z., Wu, J. Z., & Delia, D. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0567 · Cited by 96
“HCT116-Chk2 / (19) were a kind gift of Bert Vogelstein (Howard Hughes Medical Institute, Chevy Chase, MD).”
BackgroundMethylator-induced, Mismatch Repair-dependent G2Arrest Is Activated through Chk1 and Chk2
Adamson, A. W., Beardsley, D. I., Kim, W.-J., Gao, Y., Baskaran, R., & Brown, K. D. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-02-0089 · Cited by 88
“Likewise, cells deficient in Chk2 are able to trigger the G2/M checkpoint in response to IR (Jallepalli et al., 2003).”
BackgroundTao, Y., Zhang, P., Girdler, F., Frascogna, V., Castedo, M., Bourhis, J., Kroemer, G., & Deutsch, É. (2007) · Oncogene · doi:10.1038/sj.onc.1210990 · Cited by 86
Global dissociation of HuR–mRNA complexes promotes cell survival after ionizing radiation
Masuda, K., Abdelmohsen, K., Kim, M. M., Srikantan, S., Lee, E. K., Tominaga, K., Selimyan, R., Martindale, J. L., Yang, X., Lehrmann, E., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.24 · Cited by 96
Lossaint, G., Besnard, E., Fisher, D., Piette, J., & Dulić, V (2011) · Oncogene · doi:10.1038/onc.2011.135 · Cited by 83
“Chk1 might be the major G2/M checkpoint regulator (Ahn et al., 2003; Jallepalli et al., 2003; Syljuasen et al., 2006; Jin et al., 2008; Zhang et al., 2008).”
Influential3,3′-Diindolylmethane inhibits breast cancer cell growth via miR-21-mediated Cdc25A degradation
Jin, Y. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0985-0 · Cited by 84
“However, extensive effort in the mapping of phosphorylation sites in Cdc25A and the use of cells deficient in Chk2 or ATM indicate that many such sites are not required for Cdc25A-mediated G2-M checkpoint following DNA damage [37, 38].”
BackgroundLuo, Y., Lin, F.-T., & Lin, W.-C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.14.6430-6444.2004 · Cited by 81
“This conclusion is based on the following observations: (i) phosphorylation of p53 can be seen in hMLH1-deficient HCT116 cells in response to ionizing radiation (9, 24), alkylation agents (3), or NCS (Fig.”
Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53
Martinez-Rivera, M., & Siddik, Z. H. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.026 · Cited by 91
“transactivation domain in p53 stabilization and stimulation and in cell death [22,192].”
Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case–control study
Brennan, P., McKay, J., Moore, L. E., Zaridze, D. G., Mukeria, A., Szeszenia‐Dabrowska, N., Lissowska, J., Rudnai, P., Fabiánová, E., Mateș, D., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm127 · Cited by 80
“with the retinoblastoma protein) and the promyelocytic leukaemia (PML) protein (2,3), but perhaps not the p53 protein ( 4-6 ).”
BackgroundDauth, I., Krüger, J., & Hofmann, T. G. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2884 · Cited by 90
Improved methods for the generation of human gene knockout and knockin cell lines
Topaloglu, O. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni160 · Cited by 77
“Southern blot analysis was performed as in (10).”
BackgroundMethodPark, H. U., Jeong, J., Chung, J. H., & Brady, J. N. (2004) · Oncogene · doi:10.1038/sj.onc.1207644 · Cited by 81
“Chk1 is a major checkpoint kinase responsible for activation of S and G2 checkpoints (Liu et al., 2000; Zhao et al., 2002b; Chen et al., 2003; Jallepalli et al., 2003; Sorensen et al., 2003; Xiao et al., 2003; Zachos et al., 2003).”
BackgroundAutophosphorylation of Checkpoint Kinase 2 at Serine 516 Is Required for Radiation-induced Apoptosis
Wu, X., & Chen, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303795200 · Cited by 67
A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpoint
Beckerman, R., Donner, A. J., Mattia, M., Peart, M. J., Manley, J. L., Espinosa, J. M., & Prives, C. (2009) · Genes & Development · doi:10.1101/gad.1795709 · Cited by 69
“Even more compellingly, in HCT116 cells in which both Chk2 alleles have been disrupted by homologous recombination (Jallepalli et al. 2003), there was again no increase in p21 mRNA accumulation after replication stress (Fig.”
BackgroundThe S phase checkpoint: When the crowd meets at the fork
GOTTIFREDI, V, & PRIVES, C. (2005) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2005.02.011 · Cited by 68
Activated Checkpoint Kinase 2 Provides a Survival Signal for Tumor Cells
Ghosh, J. C., Dohi, T., Raskett, C. M., Kowalik, T. F., & Altieri, D. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3095 · Cited by 66
“Although Chk2 plays a role in cell cycle control (3, 4), how this pathway couples to cell survival is controversial, especially with respect to p53 (5), and is associated with activation (6–8) or inhibition (9–11) of apoptosis after stress/ DNA damage.”
BackgroundATR mediates cisplatin resistance in a p53 genotype-specific manner
Sangster-Guity, N., Conrad, B. H., Papadopoulos, N., & Bunz, F. (2011) · Oncogene · doi:10.1038/onc.2010.624 · Cited by 65
Self-citationChk2 Suppresses the Oncogenic Potential of DNA Replication-Associated DNA Damage
Stracker, T. H., Couto, S. S., Cordon‐Cardo, C., Matos, T., & Petrini, J. H. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.028 · Cited by 69
“…mice or cell lines with acute Chk2 deletion have been described in human or mouse cells expressing hypomorphic Chk2 alleles or in which siRNA-mediated depletion has been induced (Bahassi el et al., 2007; Falck et al., 2001, 2002; Jallepalli et al., 2003; Matsuoka et al., 1998; Takai et al., 2002).”
BackgroundDNA Damage during Reoxygenation Elicits a Chk2-Dependent Checkpoint Response
Freiberg, R. A., Hammond, E. M., Dorie, M. J., Welford, S. M., & Giaccia, A. J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.5.1598-1609.2006 · Cited by 63
“Furthermore, Chk2 loss is not associated with radioresistance in human cells (36, 70).”
BackgroundMethodInfluentialErtych, N., Stolz, A., Valerius, O., Braus, G. H., & Bastians, H. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525129113 · Cited by 63
Jin, J., Ang, X. L., Ye, X., Livingstone, M., & Harper, J. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802474200 · Cited by 57
Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo
Niida, H., Murata, K., Shimada, M., Ogawa, K., Ohta, K., Suzuki, K., Fujigaki, H., Khaw, A. K., Banerjee, B., Hande, M. P., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.218 · Cited by 60
“…either or both Chk1 and Chk2 in human cells failed to abrogate the damage-dependent induction of p53 expres- sion (Ahn et al, 2003), and depletion of both Chk2 alleles in human colon cancer cells does not compromise p53 phos- phorylation at S20 (corresponding to mouse S23) (Jallepalli et al, 2003).”
BackgroundChk2 is required for HSV-1 ICP0-mediated G2/M arrest and enhancement of virus growth
Han, L., Rajasekaran, B., Krisky, D. M., Bein, K., Grandi, P., Cohen, J. B., & Glorioso, J. C. (2008) · Virology · doi:10.1016/j.virol.2008.01.038 · Cited by 63
“HCT116 and HCT116(Chk2−/−) cells were a generous gift from B. Vogelstein (Johns Hopkins University, MD) (Jallepalli et al., 2003), HCT15, HCT15(Chk2+) and HCT15(Chk2-T68A) cells were generously provided by J. Chen (Mayo Clinic, Rochester, NY) (Wu and Chen, 2003), A-T lines GM05849, GM02052 and GM09607 were from Coriel…”
BackgroundMethodLønning, P. E., & Knappskog, S. (2013) · Oncogene · doi:10.1038/onc.2013.48 · Cited by 51
Dozier, C., Bonyadi, M., Baricault, L., Tonasso, L., & Darbon, J. (2004) · Biology of the Cell · doi:10.1016/j.biolcel.2004.04.010 · Cited by 53
“These data demonstrate that Chk2 is likely dispensable for initiating and maintaining the G2 arrest after genotoxic treatment (Jallepelli et al. 2003).”
BackgroundCraig, A. L., Chrystal, J. A., Fraser, J. A., Sphyris, N., Lin, Y., Harrison, B. J., Scott, M. T., Dornreiter, I., & Hupp, T. R. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01595-06 · Cited by 54
“Furthermore, additional studies indicate that neither CHK2 nor CHK1 may be a radiation-induced Ser(20) kinase in vivo (2, 30); thus, it is not evident what the actual Ser(20) kinase(s) for p53 protein might be.”
BackgroundMacip, S., Kosoy, A., Lee, S. W., O’Connell, M. J., & Aaronson, S. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209629 · Cited by 52
“However, recent reports have indicated that Chk2 does not play a role in cell cycle checkpoints (Takai et al., 2002; Jallepalli et al., 2003; Ho et al., 2005; de Vries et al., 2005) and thus is unlikely to be involved in the arrest following oxidative stress.”
BackgroundMahyar-Roemer, M., Fritzsche, C., Wagner, S., Laue, M. M., & Roemer, K. (2004) · Oncogene · doi:10.1038/sj.onc.1207637 · Cited by 48
“…arrest was induced in human HCT116 colon adenocarcinoma cells, a cell line widely used for the study of the p53 pathways (for example Bunz et al., 1998; Hwang et al., 2001; Mahyar-Roemer and Roemer, 2001; Mahyar-Roemer et al., 2001; Bunz et al., 2002; Jallepalli et al., 2003; Lohr et al., 2003).”
BackgroundDNA Damage-Induced Cell Cycle Regulation and Function of Novel Chk2 Phosphoresidues
Buscemi, G., Carlessi, L., Zannini, L., Lisanti, S., Fontanella, E., Canevari, S., & Delia, D. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00534-06 · Cited by 44
“Chk2 has been reported to phosphorylate p53, thereby enhancing the transcriptional activity of p53-responsive genes (51), although this event has been questioned in later investigations ( 28 ).”
BackgroundDNA Damage Checkpoints and Cancer
Shimada, M., & Nakanishi, M. (2006) · Journal of Molecular Histology · doi:10.1007/s10735-006-9039-4 · Cited by 57
“Chk2 likely helps to stabilize p53 protein after DNA damage, although there have been conflicting (Hirao et al. 2000; Jack et al. 2002; Takai et al. 2002; Ahn et al. 2003; Jallepalli et al. 2003).”
ResultATM-dependent CHK2 Activation Induced by Anticancer Agent, Irofulven
Wang, J., Wiltshire, T. D., Wang, Y., Mikell, C., Burks, J., Cunningham, C., Laar, E. S. V., Waters, S. J., Reed, E., & Wang, W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400015200 · Cited by 48
Rainey, M. D., Black, E. J., Zachos, G., & Gillespie, D. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210702 · Cited by 49
“, 2001) but not all cell lines in culture (Jallepalli et al., 2003).”
BackgroundInfluentialNFBD1/MDC1, 53BP1 and BRCA1 have both redundant and unique roles in the ATM pathway
Wilson, K. A., & Stern, D. F. (2008) · Cell Cycle · doi:10.4161/cc.7.22.7102 · Cited by 43
ATM and Genome Maintenance: Defining Its Role in Breast Cancer Susceptibility
Khanna, K. K., & Chenevix‐Trench, G. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000048772.92326.a1 · Cited by 49
Tse, A. N., Sheikh, T. N., Ho, A. L., Chou, T., & Schwartz, G. K. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.050807 · Cited by 50
“However, more recent studies have raised questions about the role of Chk2 in p53 induction, because Chk2 knockout or depleted cells seem to retain an intact p53 response pathway after DNA damage (Ahn et al., 2003; Jallepalli et al., 2003).”
Park, H. U., Jeong, S.-J., Jeong, J.-H., Chung, J. H., & Brady, J. N. (2005) · Oncogene · doi:10.1038/sj.onc.1209059 · Cited by 42
“A recent study with Chk2 knockout HCT-116 cells demonstrated that cells arrested in the G2 phase in the absence of Chk2 after g-IR (Jallepalli et al., 2003).”
BackgroundInoue, A., Robinson, F. S., Minelli, R., Tomihara, H., Rizi, B. S., Rose, J. L., Kodama, T., Srinivasan, S., Harris, A. L., Zuniga, A. M., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.03.022 · Cited by 42
Jack, M. T., Woo, R. A., Motoyama, N., Takai, H., & Lee, P. W. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309917200 · Cited by 39
Aris, S. M., & Pommier, Y. G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2579 · Cited by 37
“HCT116 cells with homozygotous inactivation of Chk2 (40) were also studied.”
BackgroundCaspase independence of radio-induced cell death
Zhang, P., Castedo, M., Tao, Y., Violot, D., Métivier, D., Deutsch, É., Kroemer, G., & Bourhis, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209744 · Cited by 37
Ape1 guides DNA repair pathway choice that is associated with drug tolerance in glioblastoma
Ströbel, T., Madlener, S., Tuna, S., Vose, S. C., Lagerweij, T., Würdinger, T., Vierlinger, K., Wöehrer, A., Price, B. D., Demple, B., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10013-w · Cited by 34
Functional Dissection of Mitotic Regulators Through Gene Targeting in Human Somatic Cells
Berdougo, E., Terret, M., & Jallepalli, P. V. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-993-2_2 · Cited by 34
Self-citationJin, Y., Zou, X., & Feng, X. (2010) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32833e53ea · Cited by 33
RetractedSoubeyrand, S., Schild‐Poulter, C., & Haché, R. J. G. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04319.x · Cited by 35
Liang, X., Reed, E., & Yu, J. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.5.703 · Cited by 32
Loss of the tumour-suppressor genes CHK2 and BRCA1 results in chromosomal instability
Stolz, A., Ertych, N., & Bastians, H. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381704 · Cited by 31
The essential role of TAp73 in bortezomib-induced apoptosis in p53-deficient colorectal cancer cells
Dabiri, Y., Kálmán, S., Gürth, C., Kim, J. Y., Mayer, V., & Cheng, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-05813-z · Cited by 32
RETRACTED: Oxaliplatin responses in colorectal cancer cells are modulated by CHK2 kinase inhibitors
Pires, I. M., Ward, T. H., & Dive, C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00607.x · Cited by 30
“HCT116 KO CHK2 and p53 KO cell lines and their respective wild-type (WT) controls (Jallepalli et al., 2003) were kindly provided by Professor Bert Vogelstein (The Johns Hopkins University School of Medicine).”
BackgroundMethodInfluentialRetracted
Metadata
- Authors
- Jallepalli, P. V., Lengauer, C., Vogelstein, B., & Bunz, F.
- Affiliations
- Johns Hopkins University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Bunz, Fred
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-06
- Volume
- 278
- Issue
- 23
- Pages
- 20475-20479
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2149938795
- Cited by
- 154
- References
- 45
- Citations by year
- 2025: 1 · 2023: 3 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 2 · 2017: 3 · 2016: 3 · 2015: 4 · 2014: 6 · 2013: 5 · 2012: 1
- FWCI
- 9.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6342 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Damon Runyon Cancer Research Foundation
- National Institutes of Health (CA43460)
- National Cancer Institute (CA43460)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- Chk2, p53, ionizing radiation response, p53 phosphorylation, cell cycle arrest, apoptosis, tumor suppressor, TP53 mutation, human cancer cells
- MeSH terms
- Colonic Neoplasms, DNA Damage, Exons, Humans, Phosphorylation, Protein Kinases, Tumor Cells, Cultured, Transcriptional Activation, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Tumor Suppressor Protein p53, G2 Phase, Protein Serine-Threonine Kinases, Checkpoint Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.